NO20040321L - 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar - Google Patents

5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar

Info

Publication number
NO20040321L
NO20040321L NO20040321A NO20040321A NO20040321L NO 20040321 L NO20040321 L NO 20040321L NO 20040321 A NO20040321 A NO 20040321A NO 20040321 A NO20040321 A NO 20040321A NO 20040321 L NO20040321 L NO 20040321L
Authority
NO
Norway
Prior art keywords
photosensitizers
ulcers
aminolevulinic acid
photochemistry
esters
Prior art date
Application number
NO20040321A
Other languages
English (en)
Norwegian (no)
Inventor
Jo Klaveness
Vidar Hansson
Original Assignee
Photocure Asa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Photocure Asa filed Critical Photocure Asa
Publication of NO20040321L publication Critical patent/NO20040321L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
    • A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation ; Therapies using these preparations
    • A61K41/0057—Photodynamic therapy with a photosensitizer, i.e. agent able to produce reactive oxygen species upon exposure to light or radiation, e.g. UV or visible light; photocleavage of nucleic acids with an agent
    • A61K41/0061—5-aminolevulinic acid-based PDT: 5-ALA-PDT involving porphyrins or precursors of protoporphyrins generated in vivo from 5-ALA
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Dermatology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NO20040321A 2001-07-26 2004-01-23 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar NO20040321L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB0118251.8A GB0118251D0 (en) 2001-07-26 2001-07-26 Method
PCT/GB2002/003386 WO2003011265A2 (en) 2001-07-26 2002-07-25 5-aminolevulinic acid and esters, in combination with another phtosensitizer, as photosensitizing agents in photochemotherapy, and their uses in treating wounds

Publications (1)

Publication Number Publication Date
NO20040321L true NO20040321L (no) 2004-03-19

Family

ID=9919248

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20040321A NO20040321L (no) 2001-07-26 2004-01-23 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar

Country Status (13)

Country Link
US (1) US20040259949A1 (https=)
EP (1) EP1414430A2 (https=)
JP (1) JP2005501050A (https=)
KR (1) KR20040030863A (https=)
CN (1) CN1533271A (https=)
CA (1) CA2454136A1 (https=)
CZ (1) CZ2004257A3 (https=)
GB (1) GB0118251D0 (https=)
HU (1) HUP0401192A3 (https=)
MX (1) MXPA04000647A (https=)
NO (1) NO20040321L (https=)
RU (1) RU2004105655A (https=)
WO (1) WO2003011265A2 (https=)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0018528D0 (en) 2000-07-27 2000-09-13 Photocure Asa Compounds
NL1020336C2 (nl) * 2002-04-09 2003-10-13 Photobiochem Leiden N V Toepassing van een verbinding voor de bereiding van een farmaceutisch preparaat voor het behandelen van brandwonden, en een werkwijze voor het behandelen van brandwonden.
NL1022597C2 (nl) * 2003-02-05 2004-08-06 Photobiochem N V Toepassing van een fotosensitizerverbinding voor de bereiding van een farmaceutisch preparaat, werkwijze voor het bereiden van een farmaceutisch preparaat en een werkwijze voor het behandelen van een zoogdier.
US20050154052A1 (en) * 2003-03-24 2005-07-14 Hetero Drugs Limited Novel crystalline forms of (s)-citalopram oxalate
GB0406917D0 (en) 2004-03-26 2004-04-28 Photocure Asa Compounds
GB0420888D0 (en) * 2004-09-20 2004-10-20 Photopharmica Ltd Compounds and uses
GB0424833D0 (en) * 2004-11-10 2004-12-15 Photocure Asa Method
WO2008006083A2 (en) 2006-07-07 2008-01-10 Surmodics, Inc. Beaded wound spacer device
US20090264492A1 (en) * 2006-08-29 2009-10-22 Stichting Voor De Technische Wetenschappen Pharmaceutical composition for the treatment of a fungal skin disorder and a method for the preparation thereof
AU2008337067A1 (en) * 2007-12-14 2009-06-25 Photoderma Sa Novel compounds useful in therapeutic and cosmetic methods
EP2268311A4 (en) * 2008-04-04 2014-08-27 Immunolight Llc NON-INVASIVE SYSTEMS AND IN SITU PHOTOBIOMODULATION METHODS
RU2395315C1 (ru) * 2008-12-01 2010-07-27 Государственное унитарное предприятие г. Москвы Международный научный и клинический центр "Интермедбиофизхим" (ГУП МНКЦ "Интермедбиофизхим") Способ фотодинамической терапии гнойных ран и трофических язв
GB0823472D0 (en) 2008-12-23 2009-01-28 Photocure Asa Product
GB0900461D0 (en) * 2009-01-12 2009-02-11 Photocure Asa Photodynamic therapy device
RU2526803C2 (ru) 2009-06-11 2014-08-27 ФотоКьюэр АСА Полутвердые композиции и фармацевтические продукты
GB0914287D0 (en) 2009-08-14 2009-09-30 Pci Biotech As Compositions
GB0914286D0 (en) * 2009-08-14 2009-09-30 Pci Biotech As Method
CA2790827A1 (en) 2010-03-01 2011-09-09 Photocure Asa Cosmetic compositions
EP2585111A1 (en) 2010-06-23 2013-05-01 Photocure ASA Hyperosmotic preparations comprising 5 -amino levulinic acid or derivative as photosensitizing agent
JP5991970B2 (ja) 2010-07-09 2016-09-14 フォトキュア エイエスエイ 光力学的治療または光力学的診断で使用する乾燥組成物および当該乾燥組成物を含む装置
WO2012012616A1 (en) * 2010-07-21 2012-01-26 Patty-Fu Giles Photoactive vitamin nanoparticles for the treatment of chronic wounds
CA2819810A1 (en) * 2010-12-06 2012-06-14 The University Of British Columbia Granzyme b inhibitor compositions, methods and uses for promoting wound healing
WO2012086802A1 (ja) 2010-12-24 2012-06-28 アークレイ株式会社 癌細胞の検出方法
KR101254752B1 (ko) * 2011-02-28 2013-04-15 부산대학교 산학협력단 광역동치료의 광증감제로 사용하기 위한 구연산을 이용한 아미노레불리닉산 트라이머
KR101254758B1 (ko) * 2011-02-28 2013-04-15 부산대학교병원 광역동치료의 광증감제로 사용하기 위한 이디티에이를 이용한 아미노레불리닉산 테트라머
CN103717215B (zh) * 2011-06-16 2016-08-17 思佰益药业股份有限公司 过敏性鼻炎的治疗剂
US20140316534A1 (en) 2011-10-14 2014-10-23 Photocure Asa Stent
EP2766049A1 (en) 2011-10-14 2014-08-20 Photocure ASA Photodynamic diagnosis of abnormalities of the epithelial lining of the oesophagus with the means of a 5-ala ester
RU2615870C2 (ru) 2011-12-19 2017-04-11 ФотоКьюэр АСА Устройство облучения
WO2014062839A1 (en) 2012-10-16 2014-04-24 Surmodics, Inc. Wound packing device and methods
GB201306369D0 (en) 2013-04-09 2013-05-22 Photocure As Irradiation device
EP3011972B1 (en) * 2013-06-19 2019-10-23 SBI Pharmaceuticals Co., Ltd. Medicinal composition for promoting synthesis of protoporphyrin ix
US10201457B2 (en) 2014-08-01 2019-02-12 Surmodics, Inc. Wound packing device with nanotextured surface
RU2604399C1 (ru) * 2015-12-01 2016-12-10 Сергей Владимирович Москвин Способ лазерной терапии больных трофическими язвами
RU2661084C1 (ru) * 2017-07-21 2018-07-11 Федеральное Агентство Научных Организаций Федеральное Государственное Бюджетное Научное Учреждение "Федеральный Научно-Клинический Центр Реаниматологии И Реабилитологии" (Фнкц Рр) Способ комплексного лечения пролежней у пациентов с длительной иммобилизацией
CN109453408A (zh) * 2018-11-16 2019-03-12 江南大学 抗菌创伤敷料及其制备方法
CN112062713B (zh) * 2020-08-04 2023-03-31 浙江工业大学 具铁螯合性和pdt活性的ala-hpo杂合衍生物及其制备方法与应用

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5234940A (en) * 1989-07-28 1993-08-10 Queen's University Photochemotherapeutic method using 5-aminolevulinic acid and precursors thereof
US5913884A (en) * 1996-09-19 1999-06-22 The General Hospital Corporation Inhibition of fibrosis by photodynamic therapy
GB0018528D0 (en) * 2000-07-27 2000-09-13 Photocure Asa Compounds

Also Published As

Publication number Publication date
WO2003011265A3 (en) 2003-04-24
HUP0401192A3 (en) 2005-07-28
MXPA04000647A (es) 2004-05-17
WO2003011265A2 (en) 2003-02-13
US20040259949A1 (en) 2004-12-23
GB0118251D0 (en) 2001-09-19
JP2005501050A (ja) 2005-01-13
CA2454136A1 (en) 2003-02-13
EP1414430A2 (en) 2004-05-06
CZ2004257A3 (cs) 2004-08-18
RU2004105655A (ru) 2005-04-10
KR20040030863A (ko) 2004-04-09
CN1533271A (zh) 2004-09-29
HUP0401192A2 (hu) 2004-12-28

Similar Documents

Publication Publication Date Title
NO20040321L (no) 5-aminolevulinsyre og estere i kombinasjon med andre fotosensibilisatorer, som fotosensibilisatoriske midler i fotokjemiterapi og deres anvendelser i behandling av sar
ATE388951T1 (de) Dpp-iv-inhibierende purin-derivative zur behandlung von diabetes
DE60114882D1 (de) System zum einbringen einer chirurgischen schlinge
ATE469674T1 (de) 5-aminolävulinsäure-derivate zur behandlung von akne
WO2007131112A3 (en) Methods and apparatuses for reshaping the esophagus and other body lumens
DK0784429T3 (da) Terapeutiske kombinationer af venöse dilatorer og arterielle dilatorer
JP2016529231A (ja) 医学的状態と疾患を治療するようにプラズマ状態の一酸化窒素を利用する方法
BRPI0111591B8 (pt) composto, composição farmacêutica, e, usos de um composto
NO20050450L (no) Kombinasjon av ZD6474, en inhibitor av vaskulaer endotelial vekst faktor reseptor, med radioterapi ved behandling av kreft
RU2011108486A (ru) ПРИМЕНЕНИЕ ПРОИЗВОДНЫХ ПЕПТИДА Wnt5-a ДЛЯ ЛЕЧЕНИЯ МЕЛАНОМЫ И РАКА ЖЕЛУДКА
EP1192949A4 (en) PREVENTIVE OR THERAPEUTIC DRUGS FOR TREATING FIBROSIS AND CONTAINING CHYMASE INHIBITORS AS ACTIVE INGREDIENTS
MXPA04003115A (es) Aparato y metodo electromagnetico para el tratamiento de lesiones asociadas con perfusion sanguinea inadecuada, denervacion parcial, perdida de tejido, dolor, edema, inflamacion e infeccion.
IT1312089B1 (it) Sali dell'acido asiatico e medacassico atti alla preparazione dicomposizioni farmaceutiche e cosmetiche.
DE50108339D1 (de) Verwendung von r-arylpropionsäuren zur herstellung von arzneimitteln zur behandlung von erkrankungen rheumatischer natur
JOP20190276B1 (ar) طرق وتركيبات لعلاج إسهال الحمض الصفراوي، والإسهال المرتبط باستئصال الأمعاء الدقيقة أو إزالة المرارة، ومتلازمة الأمعاء القصيرة
DK1154766T3 (da) Anvendelse af R-arylpropionsyre til fremstilling af lægemidler til behandling af sygdomme hos mennesker og dyr, hvor sygdommene kan påvirkes terapeutisk ved inhibering af aktiveringen af NF-kappa B
DE50100833D1 (de) Verwendung von 2-methyl-thiazolidin-2,4-dicarbonsäure und / oder ihrer physiologisch verträglichen salze zur herstellung eines medikaments zur behandlung von krebserkrankungen
WO2008096816A1 (ja) 血管新生誘導剤及びそれに用いられるポリペプチド
RU2460555C1 (ru) Способ лечения ожоговых ран
DE60333742D1 (de) Verwendung einer kombination von l-carnitin, acetyl l-carnitin und propionyl l-carnitin zur behandlung von oligoasthenoteratospermia
DK1818052T3 (da) Anvendelse af formoterol i den profylaktiske og/eller terapeutiske behandling af muskelsvind og/eller kakektisk syndrom i forbindelse med kataboliske forhold af visse sygdomme såsom cancer, aids, infektioner, diabetes og andre
ATE269096T1 (de) Behandlung von hypersensibilitätreaktion erkrankungen
KR20230001340A (ko) 상처 치료용 광석 밴드 와 연고
US8093215B2 (en) Method for restructuring a biological tissue comprising collagen fibrils and relative uses
BR0111546A (pt) Produto combinado, método para a produção de um kit de partes, kit de partes, método de tratamento de uma condição, usos de um produto combinado ou de um kit de partes, e, de um melagatrano e de um inibidor de fator viia, ou de um derivado farmaceuticamente aceitável dos mesmos

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application